65597-406Level 3
Enhertu (fam-trastuzumab deruxtecan-nxki)
**Product type:** Human Prescription Drug
**Active ingredient:** TRASTUZUMAB DERUXTECAN
**Strength:** 100 mg/5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Daiichi Sankyo Inc.
**Marketing category:** BLA (BLA761139)
GET
/api/v1/systems/ndc_fda/nodes/65597-406Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.